The quantity and quality of antibodies recognizing the end region of the malaria parasite’s CSP protein is a good marker of protection by the RTS,S/AS01E vaccine, shows a study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by ‘la Caixa.’ The results provide valuable information for guiding the design of future, more effective vaccines.
Source: EurekaAlert, https://www.eurekalert.org